Track the latest Viracta Therapeutics insider trading activity. Stay informed on recent buys, sells, and market impact for Viracta Therapeutics stock.
Insider trading activity involves company insiders, such as executives, directors, and employees, engaging in transactions of their own company's stock. Insiders' buy and sell transactions provide valuable insights into their confidence in the company's future performance.
Insiders have report no purchases/sales in the last 30 days.
There has been no Insider buying or selling in the last 90 days.
Feb 27, 2024 | Daniel Chevallard | CFO AND COO | 3.48K | $0.73 | -$2.49K | SELL-OPTIONS | 3.53% | 102.31K | Feb 25 - Feb 27 | View |
Dec 04, 2023 | Mark Rothera | PRESIDENT AND CEO | 100.00K | $0.49 | $49.36K | BUY | ∞ | 100.00K | Nov 30 - Dec 01 | View |
Nov 28, 2023 | Daniel Chevallard | CFO AND COO | 3.17K | $0.50 | -$1.86K | SELL-OPTIONS | 3.31% | 98.82K | Nov 25 - Nov 28 | View |
Aug 29, 2023 | Daniel Chevallard | CFO AND COO | 3.38K | $1.45 | -$5.09K | SELL-OPTIONS | 3.66% | 95.65K | Aug 25 - Aug 28 | View |
May 26, 2023 | Daniel Chevallard | CFO AND COO | 3.25K | $1.42 | -$5.16K | SELL-OPTIONS | 3.66% | 92.28K | May 25 | View |
Feb 28, 2023 | Lisa Rojkjaer | CHIEF MEDICAL OFFICER | 1.97K | $1.68 | -$3.62K | SELL-OPTIONS | 4.27% | 48.09K | Feb 25 - Feb 27 | View |
Feb 28, 2023 | Daniel Chevallard | CFO AND COO | 3.29K | $1.68 | -$6.05K | SELL-OPTIONS | 3.84% | 89.02K | Feb 25 - Feb 27 | View |
Nov 29, 2022 | Daniel Chevallard | CFO AND COO | 3.36K | $2.72 | -$9.61K | SELL-OPTIONS | 4.08% | 85.73K | Nov 25 - Nov 28 | View |
Nov 29, 2022 | Lisa Rojkjaer | CHIEF MEDICAL OFFICER | 2.01K | $2.72 | -$5.75K | SELL-OPTIONS | 4.56% | 46.12K | Nov 25 - Nov 28 | View |
Aug 29, 2022 | Lisa Rojkjaer | CHIEF MEDICAL OFFICER | 1.94K | $4.01 | -$8.79K | SELL-OPTIONS | 4.59% | 44.10K | Aug 25 - Aug 26 | View |
Aug 29, 2022 | Daniel Chevallard | CFO AND COO | 3.23K | $4.02 | -$14.68K | SELL-OPTIONS | 4.09% | 82.38K | Aug 25 - Aug 26 | View |
Aug 29, 2022 | IVOR ROYSTON | CEO & PRESIDENT | 11.84K | $4.01 | -$53.66K | SELL-OPTIONS | 1.91% | 631.37K | Aug 25 - Aug 26 | View |
May 27, 2022 | IVOR ROYSTON | CEO & PRESIDENT | 12.06K | $1.90 | -$25.02K | SELL-OPTIONS | 1.98% | 619.53K | May 25 - May 26 | View |
May 27, 2022 | Lisa Rojkjaer | CHIEF MEDICAL OFFICER | 1.97K | $1.90 | -$4.09K | SELL-OPTIONS | 4.91% | 42.17K | May 25 - May 26 | View |
May 27, 2022 | Daniel Chevallard | CFO AND COO | 3.29K | $1.90 | -$6.84K | SELL-OPTIONS | 4.34% | 79.14K | May 25 - May 26 | View |
Mar 01, 2022 | IVOR ROYSTON | CEO & PRESIDENT | 10.58K | $2.78 | -$40.68K | SELL-OPTIONS | 1.77% | 607.47K | Feb 25 - Feb 28 | View |
Mar 01, 2022 | Lisa Rojkjaer | CHIEF MEDICAL OFFICER | 1.73K | $2.78 | -$6.66K | SELL-OPTIONS | 4.50% | 40.20K | Feb 25 - Feb 28 | View |
Mar 01, 2022 | Daniel Chevallard | CFO AND COO | 2.89K | $2.78 | -$11.11K | SELL-OPTIONS | 3.96% | 75.85K | Feb 25 - Feb 28 | View |
Nov 29, 2021 | Lisa Rojkjaer | CHIEF MEDICAL OFFICER | 3.71K | $4.81 | -$21.85K | SELL-OPTIONS | 10.68% | 38.46K | Nov 25 - Nov 29 | View |
Nov 29, 2021 | Daniel Chevallard | CFO AND COO | 6.20K | $4.81 | -$36.46K | SELL-OPTIONS | 9.28% | 72.96K | Nov 25 - Nov 29 | View |
Nov 29, 2021 | IVOR ROYSTON | CEO & PRESIDENT | 22.69K | $4.81 | -$133.50K | SELL-OPTIONS | 4.00% | 589.89K | Nov 25 - Nov 29 | View |
Nov 15, 2021 | IVOR ROYSTON | CEO & PRESIDENT | 8.00K | $5.56 | $44.48K | BUY | 1.43% | 567.20K | Nov 15 | View |
Browse insider trades on all stocks.